• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从纵向数据中学习最优动态治疗方案。

Learning optimal dynamic treatment regimes from longitudinal data.

作者信息

Williams Nicholas T, Hoffman Katherine L, Díaz Iván, Rudolph Kara E

机构信息

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, United States.

Division of Biostatistics, Department of Population Health Sciences, Grossman School of Medicine, New York University, New York, NY 10016, United States.

出版信息

Am J Epidemiol. 2024 Dec 2;193(12):1768-1775. doi: 10.1093/aje/kwae122.

DOI:10.1093/aje/kwae122
PMID:38879744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11637529/
Abstract

Investigators often report estimates of the average treatment effect (ATE). While the ATE summarizes the effect of a treatment on average, it does not provide any information about the effect of treatment within any individual. A treatment strategy that uses an individual's information to tailor treatment to maximize benefit is known as an optimal dynamic treatment rule (ODTR). Treatment, however, is typically not limited to a single point in time; consequently, learning an optimal rule for a time-varying treatment may involve not just learning the extent to which the comparative treatments' benefits vary across the characteristics of individuals, but also learning the extent to which the comparative treatments' benefits vary as relevant circumstances evolve within an individual. The goal of this paper is to provide a tutorial for estimating ODTR from longitudinal observational and clinical trial data for applied researchers. We describe an approach that uses a doubly robust unbiased transformation of the conditional ATE. We then learn a time-varying ODTR for when to increase buprenorphine-naloxone dose to minimize a return to regular opioid use among patients with opioid use disorder. Our analysis highlights the utility of ODTRs in the context of sequential decision-making: The learned ODTR outperforms a clinically defined strategy. This article is part of a Special Collection on Pharmacoepidemiology.

摘要

研究人员经常报告平均治疗效果(ATE)的估计值。虽然ATE总结了治疗的平均效果,但它没有提供任何关于任何个体内部治疗效果的信息。一种利用个体信息来定制治疗以最大化益处的治疗策略被称为最优动态治疗规则(ODTR)。然而,治疗通常不限于单个时间点;因此,学习随时间变化的治疗的最优规则可能不仅涉及了解比较治疗的益处随个体特征变化的程度,还涉及了解比较治疗的益处随个体内部相关情况演变而变化的程度。本文的目的是为应用研究人员提供一个从纵向观察数据和临床试验数据估计ODTR的教程。我们描述了一种使用条件ATE的双重稳健无偏变换的方法。然后,我们为何时增加丁丙诺啡-纳洛酮剂量以尽量减少阿片类药物使用障碍患者恢复常规阿片类药物使用的情况学习一个随时间变化的ODTR。我们的分析突出了ODTR在序贯决策背景下的效用:所学习的ODTR优于临床定义的策略。本文是药物流行病学特刊的一部分。

相似文献

1
Learning optimal dynamic treatment regimes from longitudinal data.从纵向数据中学习最优动态治疗方案。
Am J Epidemiol. 2024 Dec 2;193(12):1768-1775. doi: 10.1093/aje/kwae122.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
Opioid antagonists with minimal sedation for opioid withdrawal.用于阿片类药物戒断且镇静作用极小的阿片类拮抗剂。
Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.
4
Buprenorphine for managing opioid withdrawal.丁丙诺啡用于管理阿片类药物戒断。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.
5
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.用于癌症患者和接受姑息治疗患者的阿片类药物引起的肠道功能障碍的μ-阿片受体拮抗剂。
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
6
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.口服纳曲酮用于预防曾对阿片类药物依赖的吸毒者复吸:一项系统评价与经济学评估
Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. doi: 10.3310/hta11060.
7
Short-Term Memory Impairment短期记忆障碍
8
Supervised dosing with a long-acting opioid medication in the management of opioid dependence.在阿片类药物依赖管理中使用长效阿片类药物进行监督给药。
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011983. doi: 10.1002/14651858.CD011983.pub2.
9
Buprenorphine for the management of opioid withdrawal.丁丙诺啡用于阿片类药物戒断的管理。
Cochrane Database Syst Rev. 2000(3):CD002025. doi: 10.1002/14651858.CD002025.
10
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.

本文引用的文献

1
Practical considerations for specifying a super learner.指定超级学习者的实用考虑因素。
Int J Epidemiol. 2023 Aug 2;52(4):1276-1285. doi: 10.1093/ije/dyad023.
2
Optimally Choosing Medication Type for Patients With Opioid Use Disorder.为阿片类药物使用障碍患者选择最佳药物类型。
Am J Epidemiol. 2023 May 5;192(5):748-756. doi: 10.1093/aje/kwac217.
3
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder.丁丙诺啡和美沙酮剂量策略以降低阿片类药物使用障碍治疗中复发的风险。
Drug Alcohol Depend. 2022 Oct 1;239:109609. doi: 10.1016/j.drugalcdep.2022.109609. Epub 2022 Aug 30.
4
The optimal dynamic treatment rule superlearner: considerations, performance, and application to criminal justice interventions.最优动态治疗规则超级学习者:考虑因素、性能及在刑事司法干预中的应用。
Int J Biostat. 2022 Jun 16;19(1):217-238. doi: 10.1515/ijb-2020-0127. eCollection 2023 May 1.
5
Optimizing opioid use disorder treatment with naltrexone or buprenorphine.优化纳曲酮或丁丙诺啡治疗阿片类使用障碍。
Drug Alcohol Depend. 2021 Nov 1;228:109031. doi: 10.1016/j.drugalcdep.2021.109031. Epub 2021 Sep 11.
6
Precision Medicine.精准医学
Annu Rev Stat Appl. 2019 Mar;6:263-286. doi: 10.1146/annurev-statistics-030718-105251.
7
Targeted learning ensembles for optimal individualized treatment rules with time-to-event outcomes.用于具有事件发生时间结局的最优个体化治疗规则的靶向学习集成方法。
Biometrika. 2018 Sep;105(3):723-738. doi: 10.1093/biomet/asy017. Epub 2018 May 7.
8
Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011-2017.基于证据的阿片类药物使用障碍治疗:2011-2017 年美沙酮剂量水平的全国性研究。
J Subst Abuse Treat. 2019 Jan;96:18-22. doi: 10.1016/j.jsat.2018.10.006. Epub 2018 Oct 16.
9
Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.增强型结果加权学习估计最优动态治疗方案。
Stat Med. 2018 Nov 20;37(26):3776-3788. doi: 10.1002/sim.7844. Epub 2018 Jun 5.
10
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.长效纳曲酮与丁丙诺啡-纳洛酮预防阿片类药物复发的比较效果(X:BOT):一项多中心、开放标签、随机对照试验。
Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.